位置:首页 > 蛋白库 > IMQB_ASPFN
IMQB_ASPFN
ID   IMQB_ASPFN              Reviewed;        3332 AA.
AC   B8NI19;
DT   20-JUN-2018, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2018, sequence version 2.
DT   03-AUG-2022, entry version 77.
DE   RecName: Full=Nonribosomal peptide synthetase imqB {ECO:0000303|PubMed:29182847};
DE            Short=NRPS imqB {ECO:0000303|PubMed:29182847};
DE            EC=6.3.2.- {ECO:0000305|PubMed:29182847};
DE   AltName: Full=Imizoquin biosynthesis cluster protein B {ECO:0000303|PubMed:29182847};
GN   Name=imqB {ECO:0000303|PubMed:29182847}; ORFNames=AFLA_064240;
OS   Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357
OS   / JCM 12722 / SRRC 167).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC   Aspergillus subgen. Circumdati.
OX   NCBI_TaxID=332952;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC
RC   167;
RX   PubMed=25883274; DOI=10.1128/genomea.00168-15;
RA   Nierman W.C., Yu J., Fedorova-Abrams N.D., Losada L., Cleveland T.E.,
RA   Bhatnagar D., Bennett J.W., Dean R., Payne G.A.;
RT   "Genome sequence of Aspergillus flavus NRRL 3357, a strain that causes
RT   aflatoxin contamination of food and feed.";
RL   Genome Announc. 3:E0016815-E0016815(2015).
RN   [2]
RP   INDUCTION, FUNCTION, DOMAIN, AND PATHWAY.
RX   PubMed=29182847; DOI=10.1021/acschembio.7b00731;
RA   Khalid S., Baccile J.A., Spraker J.E., Tannous J., Imran M.,
RA   Schroeder F.C., Keller N.P.;
RT   "NRPS-derived isoquinolines and lipopetides mediate antagonism between
RT   plant pathogenic fungi and bacteria.";
RL   ACS Chem. Biol. 13:171-179(2018).
CC   -!- FUNCTION: Nonribosomal peptide synthetase; part of the gene cluster
CC       that mediates the biosynthesis of imizoquins A to D, tripeptide-derived
CC       alkaloids that serve a protective role against oxidative stress that
CC       are essential for normal germination (PubMed:29182847). ImqB is a
CC       canonical three-module NRPS that assembles the tripeptide backbone of
CC       the imizoquins via condensation of Trp, Tyr, and Leu-derived precursors
CC       (PubMed:29182847). N-methylation by imqF and phenol oxidation by imqC,
CC       followed by cyclization via the FAD-dependent oxidase imqH carry out
CC       the three-step transformation of L-tyrosine into tetrahydroisoquinoline
CC       (PubMed:29182847). Importantly, this sequence requires the presence of
CC       a free amine in the tyrosine moiety, indicating that isoquinoline
CC       formation occurs prior to peptide bond formation (PubMed:29182847). The
CC       imidazolidin-4-one ring of imizoquins could form following additional
CC       oxidation of the methyl-derived bridgehead carbon by imqH
CC       (PubMed:29182847). Lastly, O-methylation by imqG and leucine
CC       hydroxylation by imqE complete biosynthesis of the imizoquins
CC       (PubMed:29182847). {ECO:0000269|PubMed:29182847}.
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000305|PubMed:29182847}.
CC   -!- INDUCTION: Expression is down-regulated by ralstonins, lipopeptides
CC       produced by the plant pathogenic bacteria Ralstonia solanacearum
CC       (PubMed:29182847). Expression is positively regulated by the imizoquins
CC       cluster-specific transcription regulator imqK (PubMed:29182847).
CC       {ECO:0000269|PubMed:29182847}.
CC   -!- DOMAIN: NRP synthetases are composed of discrete domains (adenylation
CC       (A), thiolation (T) or peptidyl carrier protein (PCP) and condensation
CC       (C) domains) which when grouped together are referred to as a single
CC       module (By similarity). Each module is responsible for the recognition
CC       (via the A domain) and incorporation of a single amino acid into the
CC       growing peptide product (By similarity). Thus, an NRP synthetase is
CC       generally composed of one or more modules and can terminate in a
CC       thioesterase domain (TE) that releases the newly synthesized peptide
CC       from the enzyme (By similarity). Occasionally, epimerase (E) domains
CC       (responsible for L- to D-amino acid conversion) are present within the
CC       NRP synthetase (By similarity). ImqB has the following architecture: A-
CC       T-C-A-T-C-A-T-TE (PubMed:29182847). {ECO:0000250|UniProtKB:Q4WAZ9,
CC       ECO:0000305|PubMed:29182847}.
CC   -!- SIMILARITY: Belongs to the NRP synthetase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=EED49603.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EQ963479; EED49603.1; ALT_SEQ; Genomic_DNA.
DR   RefSeq; XP_002379984.1; XM_002379943.1.
DR   SMR; B8NI19; -.
DR   STRING; 5059.CADAFLAP00007849; -.
DR   EnsemblFungi; EED49603; EED49603; AFLA_064240.
DR   eggNOG; KOG1176; Eukaryota.
DR   eggNOG; KOG1178; Eukaryota.
DR   HOGENOM; CLU_000022_0_12_1; -.
DR   Proteomes; UP000001875; Unassembled WGS sequence.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0043604; P:amide biosynthetic process; IEA:UniProt.
DR   GO; GO:1901566; P:organonitrogen compound biosynthetic process; IEA:UniProt.
DR   Gene3D; 1.10.1200.10; -; 3.
DR   Gene3D; 3.30.300.30; -; 3.
DR   Gene3D; 3.30.559.10; -; 2.
DR   Gene3D; 3.40.50.12780; -; 3.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR010071; AA_adenyl_domain.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   InterPro; IPR001031; Thioesterase.
DR   Pfam; PF00501; AMP-binding; 3.
DR   Pfam; PF00668; Condensation; 2.
DR   Pfam; PF00550; PP-binding; 3.
DR   Pfam; PF00975; Thioesterase; 1.
DR   SMART; SM00823; PKS_PP; 3.
DR   SUPFAM; SSF47336; SSF47336; 3.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   TIGRFAMs; TIGR01733; AA-adenyl-dom; 3.
DR   PROSITE; PS00455; AMP_BINDING; 3.
DR   PROSITE; PS50075; CARRIER; 3.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 3.
PE   2: Evidence at transcript level;
KW   Ligase; Phosphopantetheine; Phosphoprotein; Repeat.
FT   CHAIN           1..3332
FT                   /note="Nonribosomal peptide synthetase imqB"
FT                   /id="PRO_0000444550"
FT   DOMAIN          764..846
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:29182847"
FT   DOMAIN          1880..1954
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:29182847"
FT   DOMAIN          2963..3039
FT                   /note="Carrier 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:29182847"
FT   REGION          230..622
FT                   /note="Adenylation 1"
FT                   /evidence="ECO:0000305|PubMed:29182847"
FT   REGION          886..1314
FT                   /note="Condensation 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29182847"
FT   REGION          1336..1740
FT                   /note="Adenylation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29182847"
FT   REGION          1992..2402
FT                   /note="Condensation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29182847"
FT   REGION          2422..2819
FT                   /note="Adenylation 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29182847"
FT   REGION          3058..3323
FT                   /note="Thioesterase (TE) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:29182847"
FT   MOD_RES         801
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         1915
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         3000
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   3332 AA;  367538 MW;  77D3876E57D65A9C CRC64;
     MLSPAVCYHT DEGKNGYTFP NLETPKNGVV QTPVQYLIQT APLHDFCSHQ MVDLRTLLQC
     AWSRVIAQLD STTDLKADAI YGTKSKSLLE GFISEVKKSQ QSTQLENERI LTEKLLLPLN
     PRGTSSLSWL QNDLLCATGG EYGEQSTGGF ELAQCGSWIA ISASFNPLIV SSRWVNDYIE
     VFRSFLVALV VGDDELSAPE NYLTPEDCAR IRNWNSAVPP EINASILDVF SEQVKAHPGS
     TAVSGWDASL TYQELEDCAD QLAYQLQSRG VGPGMLIPLC FEKSAWTVVA IIAVISTGAA
     FVLLDASQPE ARLRSIVMQT RATLMITSSQ KKDLGRRLVP EVVSVQPTKS TKNSERSRAL
     RPVIKPDSLL YVVFTSGSTG QPKGAMISHS NFVSAVHYRR SELYNVTPRV LDFASYSFDI
     SIESTLAPLL LGGCVCVPSD ASREADPSDA IKAFNVNQVM LTPSVARLVE PENVPSLRLL
     HLGGEQISRF DIERWPSTVK LINGYGPAEC TVVSTANTVS PSSPEAHTIG RGLGAVTWVV
     DPADTGRLVP VGAVGELVIE GPLVGSGYLH DEGRTLAAFI VDPPWLRAFG RRGRLYRTGD
     LVSYNSNGTL TFIGRKDTQV KVNGQRVELG EIEHNLQQEI YNQGNCVVDV VVDLISVNSN
     SGKQSILLAF LGLERAAQER FAASGTPSVQ ELTSAMWEIL EPINLFKVLP RYMVPSIYIP
     LWRMPLLPSG KINRLKLRSM GESLSVDDLA AFRKPQVATV DTQGRITPQE KLLQSLWGQI
     FPHCAGSIQP DDNFFSLGGD SLTAMKLVGL IRKHGIENKH SETIRIADIL QWPRLADMAR
     CITRVDDKQG DVQDALFDLL PDHIAPSNAR QIAAPQCDVQ PEQIVDIYPC TPLQEGLMAL
     SAERSGAYIA QNIFELSDRT NIDTLRMAWT HIVMSSVIFR TRIVQLDSQT LAQAVVTVPI
     EWECYDGKLN DFVAIDRHRP MGIGKALMRL TVVTERSEES LLKCFLVWTA HHAVFDDWIL
     NLITSLVGKM YHGRPPSSFH LTPYKRFIRH LQELNRESFS NYWRQELEGT NAAIFPHLPS
     AVDKPVADAT ANFAFSLNDS KLNVHASLPT ILRAAWSILV SRHTQTDDVI FGETLTGRNA
     PVAGVEEMDG PTLTTIPRRV KVQNEMRVAE FLEEIRRHEI NSIPYEGFGL QNIQKLSDDA
     RTACQFATLL VIQRDPEVSF DSPMINVTEK VLHEDCGEDG KPYASFFTTY PLMVTISIKD
     NQINIYASFD SRIIERSQMQ VLMHQLEVIT RQVIQEPHEV VGGINCLTRK ELHQIWSWNR
     LPWVPVSGSV HDSIAEVSNT RPTAPAVCAW DGSLTYGELD NLSTRLGSYL FKVGVEAESL
     VPLCFEKSVW TIVSMLAVIK AGGAFVLLDP TQPKQRLGEI IVRAKANYVL TSPLQYGMVS
     DLASEFNLTI VLVSKSPLDA LTDDATVTDR MPQHLDSDRP LFVTFTSGST GKPKGVISTH
     GSYLSGVNYR RSILQLPNLD MRVFDFASYS FDVSTDVILS TLLTGGCVCV PSDFDRKNNI
     PGAINALRVN AADLTPSVSR LLSPESVPGL KVLKLGGEAN TAADHALWLG KTTLVNIYGP
     SECLVVTAKT VLPGIDPCNI GRGLGANTWV ADPTNHDRLA PIGSIGELLV EGPILGRGYL
     DDQKQTDAVF IHNPTWLVKG LPGFQPGREG RVYKTGDLVR YNPDGTLHYI GRKDRQLKVR
     GQRVEPAEIE GAIKRHMQSK LGMTIDVVAD LVTSNRDQRK RLIAFLGLNQ VLESRGYSEK
     DHLGDTVLRD IMWEVTAGLE VLLSQTLPPY MVPSVYVPLR HIPLLPSGKT DRRKLQSAAA
     SLSPEDLSFF RERPKAQNRA IATPKEEKLQ KIWADALGVK SIQAEDNFFT IGGDSIAAMR
     LVGLARDQGL LLSVADIFQR PRLYEMAEKA AETGTELLDI PAFSLLPGAN PYVIDEREVA
     AAQCGCSIEL IEDIYPCTPL QEGLMALSTK TPGAYISQNV FQMGNATNTD LMKEAWDYVV
     RSNPIMRTRV ILSARQDLVQ VTVQEGIHWA SHDSLDCYLK YDRNTSMGLG MPLTRLAWVD
     DEMTKRSFLV WTAHHAIFDG WVLSLVMENV IRVYHGKSLH VGPPFKAFIK YLKELERAQM
     DTFWQDEFSG ITATPFPALP SSTYQPKADV ETKLEMSFTW STTSNVTSST FLRLAWAVLV
     ARLTASSDVI FGETLNGRNA PIPGIERMIG PTLTTLPRRI VLEDGLPVAD LLHRLKDHEI
     AMMPFEHVGL QHLQELSADC QAACKFQTLF VVQRGMDHDM SEMSLTISGD VSNFNSYALM
     LTCAPESDKI LFHASHDSNV ISPEKMQDVL NQLQNVVMQL SKKMDRPLRE INCLSEIDTQ
     QIWKWNHQLP ESISIPVHEI IAQQAREHPA TEAVCAWDGT FTYRELDTLA GQLAYHLKEL
     GAVSTPGYHI PLCFEKSAWT VISILAVMKA GGSFVLLDVS QPQDRLQHIV SHIKANYILS
     SPRQSDLASS LAANVVVVSS DFVRSLRQLH TPGPLNPNSA LYVVFTSGST GKPKGVIITH
     LNFASGVHYR QNVMHMPGFR LLDFPSYSFD ASVESNLVPL MIGGCVCIAS DELCQNNLSA
     AISSTNANAV MLTPSSATLI SPENAHSLKQ LHLGGEKLTA ANIETWADKL KLVVGYGPAE
     CAVTTTGRIV KGMVPQKENI GPAFGAVTWL VDPASHDRLV PLGTIGELLI EGPIVGQGYV
     NDPERTAAAF IENPPWLLAG GGMFAGRQGR LYKTGDLARY DSDGTLIFIG RKDTQVKIRG
     QRVELQEIEH HVYQYLRDLT GLGLSIVADL ISTCSDIANP TLVVFIELEA VMTQKGYLPD
     PGPAVLYNEM KSMVPGLDEA LRNALPRYMI PSAYVPRWKL PMMPSGKLNR KQLRSDAESL
     TAEQWNHFRS LISAVSPAAR GREVATNDEA AVQRLWADIL RIAEKQIKAD DSFFTLGGNS
     ITAMKLVELA RRRGILFNVA DVFAHPVLSD LASRIGRVET TPLNQDDLAY APLQRLMSSN
     PTLIQGQSSN IPLVMIHDGG GTTYAYHRMG PVNRPLYGIH FPGYASGTAW KGGIKSLGRH
     YADLIQKSLL SGPIILGGWS SGGLISLEVA LCLKSGPFEV KGVIMVDSVF PAPSLVDETF
     LAPSSSETND TAMAADGTLA KMNMFQFNSM LKEYSPPRFE DLFQDLDASK AGLCHEQRSN
     VNPITEDTHH AERFPVHLLR ASSTKASIGE LDENMKSFLD ATLGWEHYRP RLVSEVDLID
     AEHYSLFSAN TVAETTRHIR DFCDRITKSR KV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024